- Benchmark ASINB084YQW9DN
- MarketplaceUK
- Category ID2826488031
- Analyzed Products
- Keywordcollagen capsules, multi collagen capsules, marine collagen capsules
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-24
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不值得进，已经是明显的低利润竞争区，而且对小商家几乎不友好。 现有数据里，新品牌只有3个，3个新品牌共5个新品里只有1个真正盈利，成功率20%，看起来不算极低，但样本太小；更关键的是，新品利润区间已经被压到0.61%~13.49%，多数新品都落在10%以下，属于价格战信号。用户50万人民币预算表面上足够做单个ASIN的前期启动，但按当前利润结构和竞争强度，这笔钱只能买入场，买不到长期胜率。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing结论很明确：这个市场不该进。 不是资金不够，而是市场已经进入明显的低利润竞争区，新品牌入场后大多直接亏损，连较强的新品牌也没跑通。你的50万预算当然覆盖得起单个ASIN的早期启动，但这只是起步钱，不足以对抗后续的品牌投入、研发和长期投放。
Early sourcing + logistics + marketing budget (GBP)£487.56 - £487.56Explains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?28.57%New listing success rate (old brands):0.00%New listing success rate (new brands):20.00%Which new brands have these successful new listings?Alternatives- 胶原蛋白粉/散装粉剂（尤其是鱼胶原或多重胶原粉）——通常每次用量更灵活、每克成本更低，也更容易加入咖啡、酸奶或奶昔，适合不想吞胶囊的人。
- 口服骨汤粉或骨汤高蛋白粉——如果用户买胶原主要是为了“蛋白质/关节/皮肤”这类泛健康诉求，这类产品往往更便宜、超市和电商都更容易买到，使用门槛也更低。
- 可溶性维生素C + 蛋白质补充方案——对想“支持自身胶原合成”的用户，维C和日常蛋白摄入（如乳清蛋白、豆蛋白）是更基础、通常更划算的替代路径。
- 透明质酸口服胶囊/片剂——如果购买动机偏向皮肤保湿和弹润，这类产品常比多重胶原更容易接受，且剂量和服用体验更简单。
- 氨糖/软骨素类关节保健补充剂——如果用户买胶囊主要是冲着关节支持，氨糖/软骨素在认知上更直接，价格带也常与胶原相近或更低，且产品选择更多。
- 日常高蛋白饮食替代（如酸奶、鸡蛋、豆制品）——对一部分只想改善皮肤、头发、指甲“营养底座”的用户，这比买胶囊更便宜、更容易持续执行。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不建议进入：新品牌新上架几乎全军覆没，整体已经偏向价格战和老品牌碾压。 用户预算50万人民币表面上够做单个ASIN，但这条赛道里真正能跑通的不是“便宜试错”，而是要么像老品牌一样持续烧投放，要么碰到极强差异化；否则大概率会像新品牌 Nutrian 和 Sealiit 一样，刚上新就卡在亏损或低利润。
New products with Highest revenueNutrian
Recent Monthly Revenue (GBP):£6,291.00(900pcs/month)B0FL87PXF1 (4.5/5 (165 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatNet profit margin below 10.00%Old brand with the most profitable new productsALPHA01
Recent Monthly Revenue (GBP):£29,970.00(3000pcs/month)B084YQW9DN (4.4/5 (2251 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableLeast investment in new productsMost investment in new productsLeast profitable new productsSealiit
Recent Monthly Revenue (GBP):-(-)B0GN4WBSHV (4.1/5 (22 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (GBP):-(-)B0GPNS9BLS (4.4/5 (29 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (GBP):£433.00(50pcs/month)B0GND3NR9K (4.2/5 (29 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatNet profit margin below 10.00%#Differentiations
Unique productsCommon productsDifferentiation:- 胶囊大剂量海洋胶原，和常见400mg款差异明显
- |
- 30粒小包装，适合试用和便携，购买门槛低
- |
- 主打皮肤+关节双重支持，受众更聚焦
B0FZXP1RBN (4.3/5 (40 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- 白绿极简袋装，外观最常规，辨识度低
- |
- 400mg基础配方与同类高度同质化
- |
- 仅30粒小包装，功能和人群都较泛
B0GN4WBSHV (4.1/5 (22 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不值得进入，已经接近价格战区，而且新品牌的真实胜率很低。 从现有样本看，能赚钱的新入场几乎只有少数老牌/强品牌打法，新品牌要么靠低价+功能差异，要么直接亏损；对小商家来说，不靠激进投放和强差异化，成功概率不高。
证据很直接：整体可识别盈利率只有20%，新产品盈利率只有14.29%，而新品牌新上架产品的盈利率只有20%（1/5），失败率高达80%（4/5）。 新产品利润结构里，低于10%利润的占比很高：所有产品中0~10%利润占33.33%，新产品里0~10%占42.86%，再加上负利润产品在新产品样本里也有28.57%，说明市场已经被低毛利挤压。更关键的是，MoovWell 这类新品牌能跑通的案例只有一个，ASIN B0FZXP1RBN，售价 £14.99，月销50，利润率17%，前期投入约1536.24美元，其中广告约359.63美元；这说明“能赢”的新品牌并不是靠普通铺货，而是靠明确功能差异和额外投放预算。相反，Sealiit 的 B0GN4WBSHV、B0GPNS9BLS 分别是 -16.25% 和 -26.06%，Revive Naturals 的 B0FKPCTVQ6 虽然有销量但利润仍只有4.98%，都属于典型的低毛利/亏损样本。老品牌里，Troo Health Care 的 B001M4YEUK 和 ALPHA01 的 B084YQW9DN 证明了大品牌更容易靠品牌力和功能组合拿结果，但这也意味着小商家很难复制它们的路径。
Profitability difficultyHigh Risk Due to Price CompetitionAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B084YQW9DNALPHA012018-10-21Yes£9.993000pcs£29970.010.46%£3134.87B0FZXP1RBNMoovWell2025-11-05Yes£13.2750pcs£663.516.96%£112.53
B001M4YEUKTroo Health Care2011-12-22Yes£8.9750pcs£448.510.43%£46.78Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0FZXP1RBNMoovWell2025-11-05Yes£13.2750pcs£663.516.96%£112.53#New Product Success Rates
Listing结论很明确：这个市场不适合现在进入，尤其不是低风险市场。 已识别的新品整体成功率只有14.29%，总体可识别盈利率只有20.00%，而新品失败占85.71%；这已经接近高风险、强竞争市场，且目前没有证据显示是可放心放量的机会。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
MoovWellNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
SealiitRevive NaturalsNutrian#Success Rate by Entry Time
Listing这不是一个值得进入的市场：新品利润被压到0.61%~13.49%，而新品牌新品整体盈利率只有14.29%，说明这里已经进入强价格战区。虽然表面上还有少数成功案例，但成功几乎只来自少数品牌，失败面明显更大；对小商家不友好，对大品牌也不是好赛道。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 2 1 0 0 0 0 2026 0 0 1 0 0 0 0 3 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 1 0 0 0 0 0 2025/8 0 0 1 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 1 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 1 0 0 0 0 3 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesTroo Health CareB001M4YEUK (4.2/5 (936 Reviews))Troo Health Troo Marine Collagen Supplement - 60 High Strength Capsules
This listing is deemed profitablePrice (GBP)£8.97Released TypeOld Release (2011-12-22)Brand is an old entry in this marketSize and Weight10.8 x 7.8 x 2.2 cm, 60.00gProfitable Factors
Established brand with longevityBased on old ASINDesign & Appearance
包装采用粉白渐变的简洁胶囊外盒，和竞品常见的袋装/功能型外观相比更偏品牌化。, 60粒高强度胶囊的常规规格，配合可投递信箱包装，属于成熟公版设计而非私模独占外形。Key Buying Motive
采用 Naticol 海洋胶原蛋白，并加入维生素C；主打更容易吸收的低分子肽，同时强调信箱友好包装。Target Customers
更适合想要日常便捷补充、偏好胶囊剂型且在意环保/旅行收纳便利的英国消费者。Early Investment
Investment
Monthly Revenue (Recent) (GBP)£448.5050 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight10.33% / 10.43%Peak / Non PeakRail Freight7.59% / 7.69%Peak / Non PeakAir Freight7.59% / 7.69%Peak / Non PeakSales & BSR Performance
Multi Collagen 2400mg – Types I, II, III, V & X – 90 Capsules – Wild Caught Marine, Grass Fed Bovine, Eggshell & Free-Range Chicken Collagen Powder, with Hyaluronic Acid & Vitamin C – by Alpha01
This listing is deemed profitablePrice (GBP)£9.99Released TypeOld Release (2018-10-21)Brand is an old entry in this marketSize and Weight20.0 x 13.0 x 1.8 cm, 64.00gProfitable Factors
Based on old ASINDistinct functions and featuresLow pricing strategyDesign & Appearance
黑色袋装包装，搭配高对比度的简洁银白字样，视觉上更像补充剂主流爆款风格。, 90粒胶囊装，便于小剂量长期补充；配方强调多来源复合胶原而不是单一海洋胶原。Key Buying Motive
复合5型胶原（I、II、III、V、X）+ 透明质酸 + 维生素C + BioPerine，功能点比常见单一海洋胶原更全。Target Customers
更适合同时关注皮肤、关节、头发和整体补充需求的消费者，而不是只想买单一鱼胶原的人。Early Investment
Investment
Monthly Revenue (Recent) (GBP)£29,970.003000 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight10.24% / 10.46%Peak / Non PeakRail Freight7.05% / 7.26%Peak / Non PeakAir Freight7.05% / 7.26%Peak / Non PeakSales & BSR Performance
Loading samples... 67%